Stay updated on T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial
Sign up to get notified when there's something new on the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page.

Latest updates to the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page
- Check5 days agoChange DetectedThe record history page shows a new revision label v3.6.6 replacing the previous v3.6.5, indicating a deployment update rather than a change to the study information.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe study record history now includes a new revision entry for v3.6.5, replacing the previous revision v3.6.4, indicating a platform update to the page.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page history shows a revision update from v3.6.3 to v3.6.4, indicating a small platform change to the study record page. No study data or content appears to be altered.SummaryDifference0.1%

- Check62 days agoChange DetectedThe study's history now includes a new revision tag, v3.6.3, replacing the previous v3.6.2. This indicates a minor update to the page's metadata reflected in the version history.SummaryDifference0.1%

- Check70 days agoChange DetectedA new revision entry v3.6.2 was added to the history, replacing v3.6.0. This reflects a minor deployment update to the page without altering study information.SummaryDifference0.1%

- Check84 days agoChange DetectedRecruitment status updated to indicate that enrollment has ended. The version history was updated to include Revision: v3.6.0 and remove Revision: v3.5.5.SummaryDifference0.5%

Stay in the know with updates to T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page.